Fig. 1From: The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization proceduresRevascularization-free survival curves in 477 subjects with T2D, according to their SAF higher vas below the median (2.6 AUs). Log-Rank: p < 0.000Back to article page